Market Overview
Acknowledging the outstanding growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global wearable injectors market share is expected to reach USD 21.98 billion by 2030 at a CAGR 15.2% throughout the forecast period 2022-2030.
The thriving wearable injectors market report is expected to register significant accruals throughout the forecast period. Factors predominantly supporting the growth of the market include the growing demand for convenient methods of drug administration and technological advancements & design development in wearable injectors.
Moreover, factors such as the favorable healthcare investments by government and the rising demand for minimally invasive devices escalates the market on the global platform.
Additional factors positively impacting the market growth include increasing cancer cases, the rising prevalence of chronic diseases, and growing uses of biologics. Also, technological advancements, improving outcomes and patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare are some of the major driving forces pushing up the market growth.
On the other hand, factors such as the stringent government regulation and the time consuming, lengthy process for product approvals alongside the preference for traditional methods of drug delivery are negatively impacting the market growth. Nevertheless, factors such as the significant growth in the home healthcare are expected to support the market growth throughout the forecast period, pushing push up the demand for wearable injectors.
Global Wearable Medical Injectors Market – Competitive Analysis
Highly competitive, the wearable injectors market overview appears to be fragmented owing to the presence of several large and small-scale players. These players invest substantially in R&D to develop advanced injectable devices. High potential growth opportunities that the market demonstrates are in turn, attracting several new entrants to the market, further intensifying the competition in the already fiercely competitive market.
Well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, partnership, and product & technology launch in order to gain a competitive advantage in this market and to maintain their market positions.
Major Players
global wearable injectors market players include Valeritas, Inc., West Pharmaceutical Services, Inc., Eli Lilly and Company, Becton, Dickinson and Company (BD), YPSOMED, Amgen Inc., CeQur SA, BioSpace, Enable Injections, SteadyMed Therapeutics, Inc., and Sensile Medical AG among others.
Global Wearable Injectors Device Market – Segments
For enhanced understanding, the report has been segmented into six key dynamics.
By Type : On-body, Off-body, and Hand-held Wearable Injectors.
By Usage : Disposable and Semi-reusable.
By Mechanism of Injection : Spring-based, Motor Driven, Rotary Pump, Expanding Battery, Pressurized Gas, and Collapsible Reservoir among others.
By Therapeutic Area : Oncology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, and Diabetes among others.
By End-user : Hospitals, Clinics, Homecare, and Ambulatory Surgery Centers among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Wearable Medical Injectors Market – Regional Analysis
The North American region, heading with the presence of several notable players is expected to retain its dominance over the global wearable injectors market outlook. Moreover, factors such as the enhanced access to technology, increasing governmental support for the research and development, and high per capita healthcare expenditures are fostering the growth of the regional market.
Besides, the availability of well-developed technologies alongside the presence of well-established infrastructure that allows implementation of advanced technology positively impacts the market growth.
The wearable injectors market in the European region holds the second position in the global market, emerging as a lucrative market. The market in the region is expanding due to the increased funding and the support provided by the government and private entities for R&D that are bringing advancements in the wearable technology. Moreover, the resurging economy in Europe is playing a vital role in the growth of the market allowing it to register a phenomenal CAGR throughout the forecast period, increasing consumers purchasing power.
The Asia Pacific region, heading with the high uptake of technology, is rapidly emerging as a profitable market for wearable injectors. Advancements in wearable technology and medical devices are one of the key driving forces behind the growth of the market in this region. The market in India, China, and Japan heading with the large technological advancements and the increasing number of healthcare solution providers predominantly contributes to the growth of the regional market.
For more information visit at MarketResearchFuture
Related Report
Peripheral Artery Disease Market
Asia Pacific Glaucoma Treatment Market
Acquired Aplastic Anemia Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian